Description
July 24, 2025:
Pathologists Anticipate Evolving Role Using Allogenic Cell Therapies
Tick Bite? Here’s What to Know About Lyme Disease and Your Next Steps
Memorial Hospital Laboratory Receives Accreditation from College of American Pathologists
#CAP25 – It's the (Reimbursement!) Circle of Life!
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Stepping into new cell therapy territories and discovering what it takes to get reimbursed, coming up next on the Path News Network Daily Edition. This is the Path News Network Daily Edition, powered by the College of American Pathologists. I'm Stevon Burrell. It's Thursday, July 24th, and here are the latest Path News headlines. Allogenic cell therapies are reshaping the clinical landscape, and pathologists are stepping into new territory. In a recent targeted oncology article, CAP member Dr. Matthew Anderson describes allogenic cell therapies as the next step in turning cells into medicine. As these off-the-shelf therapies grow, pathologists are stepping beyond diagnosis to support treatment decisions. Find the full story in our show notes. And today, as tick season ramps up, CAP member Dr. Bobbi Pritt urges quick action to stop Lyme disease before it starts. She told CNET the infection, spread by black-legged ticks, often begins with a bull's eye rash in about 70% of cases. Spot it early. Treat it fast. That's the key. Get the full story in our show notes. Big news out of Carthage, Illinois. Memorial Hospital Laboratory has officially earned accreditation from the CAP, making it one of more than 8,000 CAP-accredited facilities worldwide. Laboratory Medical Director Dr. Katherine Kasper said the accreditation reflects the lab's commitment to excellence. Find out more about Memorial Hospital Laboratory by visiting the link in the show notes. And finally, getting paid in pathology is no simple feat. and this year at CAP25, the CAP is taking it head on. In a workshop eligible for CME credit, experts will examine the full reimbursement cycle, unpacking what it really takes to secure payment. The session takes place September 13th at the annual meeting. Visit the link in the show notes to register. That's all we have for today. Be sure to follow this newscast by clicking the plus sign in the right-hand corner of this podcast player. Look for more news like this. Like this and our weekly newsletters, published every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern with more CAP News. For the Daily Edition, I'm Stevon Burrell. Have a great day.
Description
July 24, 2025:
Pathologists Anticipate Evolving Role Using Allogenic Cell Therapies
Tick Bite? Here’s What to Know About Lyme Disease and Your Next Steps
Memorial Hospital Laboratory Receives Accreditation from College of American Pathologists
#CAP25 – It's the (Reimbursement!) Circle of Life!
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Stepping into new cell therapy territories and discovering what it takes to get reimbursed, coming up next on the Path News Network Daily Edition. This is the Path News Network Daily Edition, powered by the College of American Pathologists. I'm Stevon Burrell. It's Thursday, July 24th, and here are the latest Path News headlines. Allogenic cell therapies are reshaping the clinical landscape, and pathologists are stepping into new territory. In a recent targeted oncology article, CAP member Dr. Matthew Anderson describes allogenic cell therapies as the next step in turning cells into medicine. As these off-the-shelf therapies grow, pathologists are stepping beyond diagnosis to support treatment decisions. Find the full story in our show notes. And today, as tick season ramps up, CAP member Dr. Bobbi Pritt urges quick action to stop Lyme disease before it starts. She told CNET the infection, spread by black-legged ticks, often begins with a bull's eye rash in about 70% of cases. Spot it early. Treat it fast. That's the key. Get the full story in our show notes. Big news out of Carthage, Illinois. Memorial Hospital Laboratory has officially earned accreditation from the CAP, making it one of more than 8,000 CAP-accredited facilities worldwide. Laboratory Medical Director Dr. Katherine Kasper said the accreditation reflects the lab's commitment to excellence. Find out more about Memorial Hospital Laboratory by visiting the link in the show notes. And finally, getting paid in pathology is no simple feat. and this year at CAP25, the CAP is taking it head on. In a workshop eligible for CME credit, experts will examine the full reimbursement cycle, unpacking what it really takes to secure payment. The session takes place September 13th at the annual meeting. Visit the link in the show notes to register. That's all we have for today. Be sure to follow this newscast by clicking the plus sign in the right-hand corner of this podcast player. Look for more news like this. Like this and our weekly newsletters, published every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern with more CAP News. For the Daily Edition, I'm Stevon Burrell. Have a great day.
Share
Embed
You may also like
Description
July 24, 2025:
Pathologists Anticipate Evolving Role Using Allogenic Cell Therapies
Tick Bite? Here’s What to Know About Lyme Disease and Your Next Steps
Memorial Hospital Laboratory Receives Accreditation from College of American Pathologists
#CAP25 – It's the (Reimbursement!) Circle of Life!
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Stepping into new cell therapy territories and discovering what it takes to get reimbursed, coming up next on the Path News Network Daily Edition. This is the Path News Network Daily Edition, powered by the College of American Pathologists. I'm Stevon Burrell. It's Thursday, July 24th, and here are the latest Path News headlines. Allogenic cell therapies are reshaping the clinical landscape, and pathologists are stepping into new territory. In a recent targeted oncology article, CAP member Dr. Matthew Anderson describes allogenic cell therapies as the next step in turning cells into medicine. As these off-the-shelf therapies grow, pathologists are stepping beyond diagnosis to support treatment decisions. Find the full story in our show notes. And today, as tick season ramps up, CAP member Dr. Bobbi Pritt urges quick action to stop Lyme disease before it starts. She told CNET the infection, spread by black-legged ticks, often begins with a bull's eye rash in about 70% of cases. Spot it early. Treat it fast. That's the key. Get the full story in our show notes. Big news out of Carthage, Illinois. Memorial Hospital Laboratory has officially earned accreditation from the CAP, making it one of more than 8,000 CAP-accredited facilities worldwide. Laboratory Medical Director Dr. Katherine Kasper said the accreditation reflects the lab's commitment to excellence. Find out more about Memorial Hospital Laboratory by visiting the link in the show notes. And finally, getting paid in pathology is no simple feat. and this year at CAP25, the CAP is taking it head on. In a workshop eligible for CME credit, experts will examine the full reimbursement cycle, unpacking what it really takes to secure payment. The session takes place September 13th at the annual meeting. Visit the link in the show notes to register. That's all we have for today. Be sure to follow this newscast by clicking the plus sign in the right-hand corner of this podcast player. Look for more news like this. Like this and our weekly newsletters, published every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern with more CAP News. For the Daily Edition, I'm Stevon Burrell. Have a great day.
Description
July 24, 2025:
Pathologists Anticipate Evolving Role Using Allogenic Cell Therapies
Tick Bite? Here’s What to Know About Lyme Disease and Your Next Steps
Memorial Hospital Laboratory Receives Accreditation from College of American Pathologists
#CAP25 – It's the (Reimbursement!) Circle of Life!
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Stepping into new cell therapy territories and discovering what it takes to get reimbursed, coming up next on the Path News Network Daily Edition. This is the Path News Network Daily Edition, powered by the College of American Pathologists. I'm Stevon Burrell. It's Thursday, July 24th, and here are the latest Path News headlines. Allogenic cell therapies are reshaping the clinical landscape, and pathologists are stepping into new territory. In a recent targeted oncology article, CAP member Dr. Matthew Anderson describes allogenic cell therapies as the next step in turning cells into medicine. As these off-the-shelf therapies grow, pathologists are stepping beyond diagnosis to support treatment decisions. Find the full story in our show notes. And today, as tick season ramps up, CAP member Dr. Bobbi Pritt urges quick action to stop Lyme disease before it starts. She told CNET the infection, spread by black-legged ticks, often begins with a bull's eye rash in about 70% of cases. Spot it early. Treat it fast. That's the key. Get the full story in our show notes. Big news out of Carthage, Illinois. Memorial Hospital Laboratory has officially earned accreditation from the CAP, making it one of more than 8,000 CAP-accredited facilities worldwide. Laboratory Medical Director Dr. Katherine Kasper said the accreditation reflects the lab's commitment to excellence. Find out more about Memorial Hospital Laboratory by visiting the link in the show notes. And finally, getting paid in pathology is no simple feat. and this year at CAP25, the CAP is taking it head on. In a workshop eligible for CME credit, experts will examine the full reimbursement cycle, unpacking what it really takes to secure payment. The session takes place September 13th at the annual meeting. Visit the link in the show notes to register. That's all we have for today. Be sure to follow this newscast by clicking the plus sign in the right-hand corner of this podcast player. Look for more news like this. Like this and our weekly newsletters, published every Tuesday and Thursday. We're back tomorrow at 5 a.m. Eastern with more CAP News. For the Daily Edition, I'm Stevon Burrell. Have a great day.
Share
Embed
You may also like
